Madrigal Pharmaceuticals Aktie
297,90
EUR
+2,60
EUR
+0,88
%
334,13
USD
-14,23
USD
-4,08
%
Werbung
Madrigal Pharmaceuticals Aktie Analyse
10.06.19 | Madrigal Pharmaceuticals Buy | B. Riley FBR | |
28.02.19 | Madrigal Pharmaceuticals Buy | H.C. Wainwright & Co. | |
14.12.18 | Madrigal Pharmaceuticals Outperform | Wolfe Research | |
12.12.18 | Madrigal Pharmaceuticals Neutral | B. Riley FBR | |
01.06.18 | Madrigal Pharmaceuticals Outperform | Oppenheimer & Co. Inc. | |
01.06.18 | Madrigal Pharmaceuticals Buy | H.C. Wainwright & Co. | |
30.01.18 | Madrigal Pharmaceuticals Buy | H.C. Wainwright & Co. | |
06.12.17 | Madrigal Pharmaceuticals Buy | H.C. Wainwright & Co. | |
Werbung
|
|||
29.11.17 | Madrigal Pharmaceuticals Buy | H.C. Wainwright & Co. |
Werbung
Werbung